China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Zhejiang-Drug

More Like This

PR Newswire associated0

Hope Rising in Hainan: International NUT Carcinoma Center Launches in Boao

Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA

HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

PR Newswire associated0

U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

PR Newswire associated0

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma

Lundbeck's bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies